The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a ...

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration that would require Medicare and Medicaid to cover anti-obesity drugs, ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Medicare is a government program that provides health insurance coverage for senior citizens age 65 years and older, the disabled of any age, and to anyone suffering from end-stage renal disease.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...

A St. Louis-area doctor who was running two urgent care locations was sentenced Wednesday for over $700,000 worth of fraud ...

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Policy makers should continue to provide clear rules of the road, increase transparency, apply more effective oversight, and ...